Leslie Claire Licari, Eugenio Bologna, Francesco Ditonno, Antonio Franco, Francesco Lasorsa, Gabriele Bignante, Flavia Proietti, Costantino Leonardo, Uzoma A Anele, Edward E Cherullo, Laurence A Levine, Riccardo Autorino, Celeste Manfredi
{"title":"缺血性前列腺增生症的当代治疗:基于美国大型数据库的 12 年人口分析。","authors":"Leslie Claire Licari, Eugenio Bologna, Francesco Ditonno, Antonio Franco, Francesco Lasorsa, Gabriele Bignante, Flavia Proietti, Costantino Leonardo, Uzoma A Anele, Edward E Cherullo, Laurence A Levine, Riccardo Autorino, Celeste Manfredi","doi":"10.1111/andr.13740","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Priapism is a urological condition characterized by a persistent erection. The management varies based on its subclassifications. Despite established clinical guidelines for ischemic priapism, there is a lack of large-scale research focused on patient characteristics and management strategies.</p><p><strong>Objectives: </strong>To analyze the contemporary management of ischemic priapism in the US, exploring patient demographics and clinical characteristics, as well as predictors of erectile dysfunction (ED) and penile prosthesis implantation (PPI).</p><p><strong>Materials and methods: </strong>We performed a retrospective analysis of the PearlDiver Mariner database, reviewing records from 2010-2021. Adult males diagnosed with ischemic priapism were included. Data analysis covered demographic, clinical variables, and management strategies. Predictors of de novo ED and PPI were evaluated using multivariable logistic regression analysis.</p><p><strong>Results: </strong>Of 36,120 patients, most (93%) received only medical management, and a minority underwent surgical interventions (penile shunt surgery [PSS], PPI or both). Medical management was typically effective, as 67.08% of the patients in this group experienced only one episode of priapism. However, de novo ED occurred in 16.57% of these patients. The majority of patients undergoing PPI had an inflatable prosthesis (81%). Older age (odds ratio, OR 1.02), the presence of metabolic diseases (OR 1.39), neurogenic disorders (OR 1.72), solid pelvic malignancies (OR 1.09), and multiple episodes of priapism were identified as significant predictors of de novo ED (all p < 0.05). Similarly, age (OR 1.03), the presence of metabolic diseases (OR 1.23), solid pelvic malignancies (OR 1.99), and multiple episodes of priapism were associated with higher likelihood of PPI (all p < 0.05).</p><p><strong>Conclusion: </strong>Most cases of ischemic priapism are managed with the medical therapy. Less than 3% of patients with ischemic priapism receive PPI, and when this occurs an inflatable prosthesis is favored. Age, specific comorbidities, and multiple episodes of priapism appear to be significant predictors of ED and PPI.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Contemporary management of ischemic priapism: A 12-year population-based analysis from a large US database.\",\"authors\":\"Leslie Claire Licari, Eugenio Bologna, Francesco Ditonno, Antonio Franco, Francesco Lasorsa, Gabriele Bignante, Flavia Proietti, Costantino Leonardo, Uzoma A Anele, Edward E Cherullo, Laurence A Levine, Riccardo Autorino, Celeste Manfredi\",\"doi\":\"10.1111/andr.13740\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Priapism is a urological condition characterized by a persistent erection. The management varies based on its subclassifications. Despite established clinical guidelines for ischemic priapism, there is a lack of large-scale research focused on patient characteristics and management strategies.</p><p><strong>Objectives: </strong>To analyze the contemporary management of ischemic priapism in the US, exploring patient demographics and clinical characteristics, as well as predictors of erectile dysfunction (ED) and penile prosthesis implantation (PPI).</p><p><strong>Materials and methods: </strong>We performed a retrospective analysis of the PearlDiver Mariner database, reviewing records from 2010-2021. Adult males diagnosed with ischemic priapism were included. Data analysis covered demographic, clinical variables, and management strategies. Predictors of de novo ED and PPI were evaluated using multivariable logistic regression analysis.</p><p><strong>Results: </strong>Of 36,120 patients, most (93%) received only medical management, and a minority underwent surgical interventions (penile shunt surgery [PSS], PPI or both). Medical management was typically effective, as 67.08% of the patients in this group experienced only one episode of priapism. However, de novo ED occurred in 16.57% of these patients. The majority of patients undergoing PPI had an inflatable prosthesis (81%). Older age (odds ratio, OR 1.02), the presence of metabolic diseases (OR 1.39), neurogenic disorders (OR 1.72), solid pelvic malignancies (OR 1.09), and multiple episodes of priapism were identified as significant predictors of de novo ED (all p < 0.05). Similarly, age (OR 1.03), the presence of metabolic diseases (OR 1.23), solid pelvic malignancies (OR 1.99), and multiple episodes of priapism were associated with higher likelihood of PPI (all p < 0.05).</p><p><strong>Conclusion: </strong>Most cases of ischemic priapism are managed with the medical therapy. Less than 3% of patients with ischemic priapism receive PPI, and when this occurs an inflatable prosthesis is favored. Age, specific comorbidities, and multiple episodes of priapism appear to be significant predictors of ED and PPI.</p>\",\"PeriodicalId\":3,\"journal\":{\"name\":\"ACS Applied Electronic Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Electronic Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/andr.13740\",\"RegionNum\":3,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, ELECTRICAL & ELECTRONIC\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/andr.13740","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0
摘要
背景:阴茎持续勃起症是一种以持续勃起为特征的泌尿系统疾病。根据其亚分类,治疗方法各不相同。尽管针对缺血性勃起功能障碍制定了临床指南,但缺乏针对患者特征和管理策略的大规模研究:目的:分析美国当代缺血性尿道前列腺肥大症的治疗情况,探讨患者的人口统计学特征、临床特征以及勃起功能障碍(ED)和阴茎假体植入(PPI)的预测因素:我们对 PearlDiver Mariner 数据库进行了回顾性分析,回顾了 2010-2021 年的记录。研究对象包括确诊为缺血性阴茎前列腺肥大症的成年男性。数据分析涵盖了人口统计学、临床变量和管理策略。使用多变量逻辑回归分析评估了新发 ED 和 PPI 的预测因素:在36120名患者中,大多数(93%)只接受了药物治疗,少数接受了手术干预(阴茎分流手术[PSS]、PPI或两者兼有)。药物治疗通常很有效,因为这组患者中有 67.08% 只经历过一次尿崩症发作。然而,其中16.57%的患者出现了新的ED。大多数接受 PPI 治疗的患者都安装了充气假体(81%)。年龄较大(几率比,OR 1.02)、患有代谢性疾病(OR 1.39)、神经源性疾病(OR 1.72)、盆腔实体性恶性肿瘤(OR 1.09)以及多次发生尿崩症被认为是导致新发尿崩症的重要预测因素(均为 p):大多数缺血性尿失禁病例可通过药物治疗得到控制。只有不到 3% 的缺血性前列腺增生症患者接受了 PPI 治疗,如果出现这种情况,则更倾向于使用充气假体。年龄、特定的合并症和多次发作的尿失禁似乎是预测 ED 和 PPI 的重要因素。
Contemporary management of ischemic priapism: A 12-year population-based analysis from a large US database.
Background: Priapism is a urological condition characterized by a persistent erection. The management varies based on its subclassifications. Despite established clinical guidelines for ischemic priapism, there is a lack of large-scale research focused on patient characteristics and management strategies.
Objectives: To analyze the contemporary management of ischemic priapism in the US, exploring patient demographics and clinical characteristics, as well as predictors of erectile dysfunction (ED) and penile prosthesis implantation (PPI).
Materials and methods: We performed a retrospective analysis of the PearlDiver Mariner database, reviewing records from 2010-2021. Adult males diagnosed with ischemic priapism were included. Data analysis covered demographic, clinical variables, and management strategies. Predictors of de novo ED and PPI were evaluated using multivariable logistic regression analysis.
Results: Of 36,120 patients, most (93%) received only medical management, and a minority underwent surgical interventions (penile shunt surgery [PSS], PPI or both). Medical management was typically effective, as 67.08% of the patients in this group experienced only one episode of priapism. However, de novo ED occurred in 16.57% of these patients. The majority of patients undergoing PPI had an inflatable prosthesis (81%). Older age (odds ratio, OR 1.02), the presence of metabolic diseases (OR 1.39), neurogenic disorders (OR 1.72), solid pelvic malignancies (OR 1.09), and multiple episodes of priapism were identified as significant predictors of de novo ED (all p < 0.05). Similarly, age (OR 1.03), the presence of metabolic diseases (OR 1.23), solid pelvic malignancies (OR 1.99), and multiple episodes of priapism were associated with higher likelihood of PPI (all p < 0.05).
Conclusion: Most cases of ischemic priapism are managed with the medical therapy. Less than 3% of patients with ischemic priapism receive PPI, and when this occurs an inflatable prosthesis is favored. Age, specific comorbidities, and multiple episodes of priapism appear to be significant predictors of ED and PPI.